Mahmoud Labib

Dr. Mahmoud Labib is a Lecturer at the Peninsula Medical School (Faculty of Health) at the University of Plymouth. His expertise lies in developing innovative diagnostic and therapeutic approaches for cancer, leveraging nanotechnology and microfluidics. He holds a Ph.D. in Biotechnology from Lund University (2009) and has conducted postdoctoral research across institutions in Canada, the US, and the UK, including roles at the University of Toronto and Northwestern University.

Education:

• Ph.D. in Biotechnology, Lund University, Sweden (2009)
• Postdoctoral Studies: Western University (Canada), University of Ottawa (Canada), University of Toronto (Canada), and Northwestern University (USA)

Research Interests: Dr. Labib focuses on advancing cancer diagnostics and therapeutics, with a particular emphasis on nanotechnology-based platforms for detecting biomarkers in liquid biopsies. His work integrates microfluidic devices, immunomagnetic cell sorting, and aptamer technologies to profile rare cells such as circulating tumor cells and tumor-reactive lymphocytes. His innovations aim to improve early detection, precision medicine, and therapeutic delivery systems.

Articles Trends: His recent publications highlight advancements in microfluidic systems for high-throughput screening, magnetic cytometry for rare cell analysis, and nanomaterial-enabled detection of cancer-related biomarkers. These studies underscore his contribution to translating nanotechnology into clinical diagnostics.

Labs/Teams: His research is conducted within the Peninsula Medical School’s interdisciplinary environment, collaborating with teams specializing in biomedical engineering and oncology. His lab develops cutting-edge tools for single-cell analysis and biomarker discovery.

Teaching: At Plymouth, he teaches modules in physiology, renal systems, and cardiac muscle biology to medical and diagnostic radiography students.